Acerus Pharmaceuticals (OTCMKTS:TRLPF) Sets New 52-Week High at $2.20

Acerus Pharmaceuticals Co. (OTCMKTS:TRLPF – Get Rating)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $2.20 and last traded at $2.20, with a volume of 109 shares trading hands. The stock had previously closed at $3.37.

The stock has a fifty day moving average of $2.20 and a 200 day moving average of $0.80. The company has a quick ratio of 0.90, a current ratio of 1.35 and a debt-to-equity ratio of 0.64.

About Acerus Pharmaceuticals (OTCMKTS:TRLPF)

Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for men's and women's health. The company offers Natesto, a nasal gel for testosterone replacement therapy in adult males diagnosed with hypogonadism; Estrace, an oral tablet for the symptomatic relief of menopausal symptoms; and UriVarx, a natural health product that helps reduce symptoms of hyperactive bladder, such as daytime urinary frequency, urgency, and nocturia.

See Also

• Get a free copy of the StockNews.com research report on Acerus Pharmaceuticals (TRLPF)
• ABM Industries, A Clean Play For Dirty Economic Times 
• Should Silver Stocks Be A Part Of Your Portfolio?
• This Still Isn’t A Buyable Bottom For Stocks 
• Dividend-Paying Midstream Oil Companies That Could Help You The Mitigate Market Volatility
• Don’t Get Too Bullish On Lennar Even Though It’s A Good Buy 

Want More Great Investing Ideas?